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Article summary
  Patient-specific finite element (Fe) models 
are evaluated on their ability to identify 
patients at risk of pathological femoral 
fracturing resulting from metastatic bone 
disease.
  These Fe results are compared with clini-
cal fracture locations and judgements of 
experienced clinicians.
Key messages
  The Fe model was more accurate at iden-
tifying patients with a high fracture risk 
compared with experienced clinicians, 
but slightly less accurate in identifying 
patients with a low fracture risk.
  Fracture locations were well predicted by 
the Fe model when compared with post-
fracture radiographs.
  Fe models can be a valuable tool to 
improve clinical fracture risk predictions 
in metastatic bone disease.
Strengths and limitations
  We performed a prospective multicentre 
patient study.
can patient-specific finite element models 
better predict fractures in metastatic bone 
disease than experienced clinicians? 
ToWards comPuTaTioNal modelliNg iN daily cliNical PracTice
Objectives
In this prospective cohort study, we investigated whether patient-specific finite element 
(Fe) models can identify patients at risk of a pathological femoral fracture resulting from 
metastatic bone disease, and compared these Fe predictions with clinical assessments by 
experienced clinicians.
Methods
A total of 39 patients with non-fractured femoral metastatic lesions who were irradiated for 
pain were included from three radiotherapy institutes. During follow-up, nine pathological 
fractures occurred in seven patients. Quantitative cT-based Fe models were generated for 
all patients. Femoral failure load was calculated and compared between the fractured and 
non-fractured femurs. Due to inter-scanner differences, patients were analyzed separately 
for the three institutes. In addition, the Fe-based predictions were compared with fracture 
risk assessments by experienced clinicians.
Results
In institute 1, median failure load was significantly lower for patients who sustained a frac-
ture than for patients with no fractures. In institutes 2 and 3, the number of patients with a 
fracture was too low to make a clear distinction. Fracture locations were well predicted by 
the Fe model when compared with post-fracture radiographs. The Fe model was more accu-
rate in identifying patients with a high fracture risk compared with experienced clinicians, 
with a sensitivity of 89% versus 0% to 33% for clinical assessments. specificity was 79% for 
the Fe models versus 84% to 95% for clinical assessments.
Conclusion
Fe models can be a valuable tool to improve clinical fracture risk predictions in metastatic 
bone disease. Future work in a larger patient population should confirm the higher predic-
tive power of Fe models compared with current clinical guidelines.
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  Patient-specific Fe analysis is an objective method for 
the prediction of fracture risk.
  in future studies, the number of patients should be 
increased, and a solution for inter-scanner differences 
needs to be found.
introduction
cancers of the breast, prostate, lung, kidney, and thyroid 
can metastasize to bone.1-3 These metastases can cause 
pain and, when left untreated, carry a risk of developing 
complications such as pathological fractures or, in case of 
vertebral metastases, spinal cord compression.1,2,4 Patho-
logical fractures in extremities affect quality of life as they 
hamper the patient’s mobility and self-care.
Femoral metastases with a low risk of fracture can be 
treated conservatively with local radiotherapy. metastases 
with a high risk of fracture require prophylactic surgery to 
retain stability of the bone.5 This is an invasive procedure 
requiring anaesthesia, which is generally complex in can-
cer patients with limited life expectancy and deteriorat-
ing condition. Thus, the decision to proceed with either a 
non-invasive treatment or a prophylactic surgical treat-
ment should be carefully made.
However, current clinical practice lacks an accurate 
tool to guide clinicians to the correct treatment decision. 
Numerous studies have evaluated lesion or patient fac-
tors on the probability of impending fractures; however, 
none has shown a sufficient predictive power.5 a poten-
tial tool to improve clinical fracture risk assessments is 
finite element (Fe) modelling, which has been shown to 
predict human femoral bone strength fairly accurately.6-10 
our group have shown that the Fe model accurately cal-
culated failure load and fairly predicted fracture locations 
in cadaver femurs with and without artificial lesions com-
pared with mechanical experiments.11-13 moreover, we 
demonstrated that ranking on Fe failure load better 
resembled the experimentally measured failure loads 
than rankings by experienced clinicians.11
in this prospective cohort study, we investigated 
whether our subject-specific Fe models are able to identify 
patients at risk of pathological femoral fractures resulting 
from metastatic bone disease. For this purpose, we included 
patients referred for radiotherapy to treat painful femoral 
metastases. against expectations, some of these patients 
sustained pathological fractures in the femur during follow-
up. We calculated the femoral failure loads and compared 
those between patients who did or did not sustain a frac-
ture. in addition, we compared the Fe predictions with 
assessments by experienced clinicians. We hypothesized 
that the Fe models more accurately identify patients with a 
high fracture risk than experienced clinicians.
Patients and Methods
Study design. Between august 2006 and september 
2009, all patients referred for palliative radiotherapy of 
the femur to three participating radiotherapy institutes 
in the Netherlands (radboud university medical center 
(institute 1), radiotherapeutic institute Friesland (insti-
tute 2), and leiden university medical center (institute 3) 
were asked to participate in this prospective cohort study. 
globally, 20% to 25% of the eligible patients participated. 
ethical approval was obtained from all participating cen-
tres. These patients received palliative radiotherapy fol-
lowing dutch clinical guidelines. lesions with an axial 
cortical involvement < 30 mm have an expected low risk 
of fracture (< 5%) and were treated with a single dose of 
8 gy.5 if the axial cortical involvement was > 30 mm, the 
risk of fracture is estimated at 23%.14 These patients were 
referred for prophylactic surgery and therefore excluded 
from this study.5 if the patient’s condition was such 
table i. inclusion criteria
inclusion criteria
Proven malignancy
Karnofsky16 performance status ⩾ 60
No clinical or radiological evidence of pathological fracturing of the femur
No prior palliative surgery for the current treatment site of the femur
No planned surgical intervention of the femoral bone
No systemic radiotherapy 30 days prior to entry into the study
No previous radiotherapy to the current treatment site of the femur
Patient is able and willing to fill out baseline and follow-up forms on pain 
and quality of life
Patient is willing to undergo additional cT scans for the femoral region
Load
application
Fixation of the model by
means of springs
Fig. 1
Boundary conditions for the finite element model. The model was distally 
fixed by springs with a very high stiffness and the load was applied by means 
of a cup on the head of the femur, which incrementally displaced in a distal 
direction.
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that surgery was undesirable or impossible, the patient 
was referred for multiple fraction radiotherapy (e.g. 5 
or 6 × 4 gy) to induce remineralization of the bone.15 
These patients were included in this study. Further inclu-
sion criteria are depicted in Table i.16 during the study 
period, 62 patients gave their consent. The patients were 
grouped according to the predominant appearance of 
their bone metastases (i.e. lytic or blastic). We excluded 
patients who had predominant blastic lesions (n = 16). 
although blastic lesions generally lead to a decreased 
structural bone strength,17 in this study the femoral 
bone strength was overestimated, probably due to the 
high degree of mineralization which resulted in unreal-
istically strong material properties in the Fe model (see 
supplementary information). additionally, patients who 
had no body weight (BW) recorded (n = 5) or sustained 
a femoral fracture more than a year after inclusion (n = 1) 
were excluded. one patient sustained a femoral fracture 
following a fall and was therefore excluded. This led to 
inclusion of 39 patients with predominant lytic bone 
lesions in this study.
Baseline characteristics of all patients were recorded 
before radiotherapy. Furthermore, quantitative com-
puted tomography (QcT) scans of the femoral region 
were retrieved prior to, at 28, and at 70 days after radio-
therapy. Patients referred for multiple fraction radiother-
apy underwent an additional QcT scan on the final day 
of their radiation schedule to capture the potential short-
term effect of multiple fraction radiotherapy.18 Through 
follow-up questionnaires and hospital records, patients 
were actively followed for six months or until a fracture 
occurred or until death, as competing risk, whichever 
occurred first. Based on having sustained a fracture, the 
patients were divided into either the fracture (F) group or 
the non-fracture (NF) group. additionally, after two 
years, data on fractures and death were updated with the 
use of hospital records.
Different Ct scanners. recent work by carpenter et al19 
has shown that the use of different cT scanners can have 
a significant effect on bone mineral density measure-
ments and subsequent calculated failure loads, which 
is difficult to correct for. in the current study, the three 
institutes used two different types of cT scanner, Philips 
Big Bore Brilliance (institute 1) and Philips acQsim cT 
(institute 2 and 3), both manufactured by Philips medical 
systems, eindhoven, The Netherlands. although QcT 
scan settings were protocolized as far as possible, inter-
scanner effects may have been present in the input to our 
Fe models, which could potentially lead to incorrect or at 
least incomparable Fe failure loads. Therefore, apart from 
a group analysis, we also analyzed the data individually 
for the three institutes to circumvent such inter-scanner 
differences. it should be noted that our previous ex vivo 
validation study was conducted using the scanning 
equipment of institute 1.11-13
Fe modelling. Patient-specific femoral Fe models were 
generated, for the greater part, using the workflow 
reported previously.11 summarizing, QcT images were 
generated using a standard protocol (as far as allowed 
by clinical practice), with the following settings: 120 kvp, 
220 ma, slice thickness 3 mm, pitch 1.5, spiral and stan-
dard reconstruction, in-plane resolution 0.9375 mm. The 
patient-specific femoral geometry was segmented from 
the most recent cT images available and converted to 
a 3d surface mesh (mimics 11.0 and 14.0, materialise, 
leuven, Belgium) and a solid mesh consisting of 
table ii. characteristics of the patients who sustained a fracture during follow-up
Patient Gender Age at 
inclusion, yrs
Femur treatment dose, 
(fractions, n)
time to 
fracture, days
type of fracture Activity while 
fracture occurred
Patient 1 male 70 right femur (F1) 24 gy (6) 123 Neck of femur fracture Walking
 left femur (F2) 24 gy (6) 123 Neck of femur fracture Walking
Patient 2 Female 53 right femur (F3) 8 gy (1) 92 Pertrochanteric fracture spontaneously
 left femur (F4) N/a 92 Neck of femur fracture spontaneously
Patient 3 male 64 left femur (F5) 24 gy (6) 7 subtrochanteric fracture spontaneously
Patient 4 Female 66 left femur (F6) 24 gy (6) 13 Neck of femur fracture spontaneously
Patient 5 Female 62 right femur (F7) 24 gy (6) 3 unknown unknown
Patient 6 male 89 right femur (F8) 8 gy (1) 237 diaphyseal fracture spontaneously
Patient 7 Female 80 left femur (F9) N/a 133 Neck of femur fracture unknown
N/a, not applicable
table iii. Femurs and patients included in each of the institutes
institute 1* institute 2† institute 3‡
Femurs Patients Femurs Patients Femurs Patients
Fracture group (F) 5 3 3 3 1 1
Non-fracture group (NF) 11 8 23 22 4 4
*one patient in institute 1 fractured both femurs, but was only radiated on the right side
†one patient in institute 2 was radiated on both sides, but only fractured her right femur, leaving her left femur in the NF group
‡one patient in institute 3 fractured her non-treated femur, leaving her treated femur in the NF group
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tetrahedral elements (average element volume 1.0 mm3; 
Patran 2005r2, msc software corporation, santa ana, 
california), subsequently. a solid calibration phantom 
containing known calcium equivalent densities (image 
analysis, columbia, Kentucky) was scanned along with 
the patient at the level of the proximal femur. since pilot 
tests showed that calibration in diaphyseal slices was 
most accurate due to beam hardening in more proximal 
slices, we performed a mean diaphyseal slice calibration 
to convert the grey values to calcium equivalent den-
sities, ash densities, and non-linear isotropic material 
behaviour, respectively, based on the material model 
of Keyak et  al.7 in this material model, the post-failure 
material behaviour for each element is represented by 
an initial perfectly plasticity phase, followed by a strain 
softening phase and finally an indefinite perfectly plastic 
phase.7 However, in case patients’ limbs were supported 
by a cushion to diminish pain during cT scanning, an air 
gap between calibration phantom and patient was pres-
ent, leading to an artefact in the calibration phantom at 
the diaphyseal level. in such cases, we used more proxi-
mal slices for calibration.
The Fe simulations of the proximal femur were per-
formed using msc.marc (2007r1; msc software 
corporation). The Fe models were loaded by displacing 
a cup on the head of the femur in the axial direction, 
while distally fixed at the knee joint centre by two bun-
dles of high-stiffness (200 000 000 N/m) springs (Fig. 1), 
which roughly resembles single-legged stance. Force-
displacement curves were made based on displacement 
and contact normal forces that were registered for each 
increment. The maximum total reaction force determined 
the failure load of the femur, which was normalized for 
BW. The failure location was defined by elements that had 
plastically deformed at the moment of structural failure, 
and was compared with the post-fracture radiograph.
Clinical assessment. To compare the Fe predictions with 
clinical fracture risk assessments, we generated digitally 
reconstructed radiographs (drrs) from the cT scans in 
this study.20 We asked two radiation oncologists with 
broad expertise in palliative radiotherapy, who regularly 
discuss and refer patients to the orthopaedics department 
(c1 and c2), and one experienced orthopaedic oncology 
surgeon (c3) to individually assess the drrs just as in 
table iV. Baseline characteristics
Fracture group (F) (n = 9)* Non-fracture group (NF) (n = 38)* p-value
Gender, n (%)  
male 4 (44) 20 (53) 0.7†
Female 5 (56) 18 (47)  
median age, yrs (iQr) 66.0 (57.5 to 75.0) 62.5 (52.8 to 76.5) 0.5‡
median body weight, kg (iQr) 73.0 (63.0 to 76.5) 76.0 (57.8 to 87.3) 0.6‡
Radiation schedule, n (%)§  
single fraction  4 (44) 15 (39) 1†
multiple fractions  5 (56) 23 (61)  
median Karnofsky performance status (iQr) 80.0 (70.0 to 80.0) 80.0 (70.0 to 90.0) 0.6‡
median time since primary tumour, yrs (iQr) 3.6 (1.7 to 6.5) 3.3 (0.8 to 5.5) 0.8‡
median time since first metastasis, yrs (iQr) 3.2 (0.1 to 3.6) 1.1 (0.1 to 2.8) 0.5‡
Primary cancer site, n (%)  
Breast 2 (22) 11 (29) 0.3¶
lung 2 (22) 5 (13)  
Prostate 2 (22) 12 (32)  
Kidney 0 (0) 4 (11)  
rectum 0 (0) 2 (5)  
multiple myeloma 3 (33) 2 (5)  
urethra 0 (0) 1 (3)  
acuP** 0 (0) 1 (3)  
median time to death since inclusion, mths (iQr)†† 11.0 (4.0 to 13.0)  8.0 (3.0 to 17.0) 0.9‡
institute, n (%)  
1 5 (56) 11 (29) 0.3¶
2 3 (33) 23 (61)  
3 1 (11) 4 (11)  
lesion type, n (%)  
Not visible 1 (11) 3 (8) 0.4¶
lytic 1 (11) 13 (34)  
mixed 7 (78) 22 (58)  
*Fracture group: nine femurs in seven patients. Non-fracture group: 38 femurs in 34 patients. Two patients had one fractured and one non-fractured femur
†Fisher’s exact test
‡mann–Whitney u test
§Two femurs in the fracture group were not treated with radiotherapy
¶chi-squared test
**cancer of unknown primary origin
††date of death missing for three non-fracture patients
iQr, interquartile range
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daily practice, without providing any further information. 
First, they indicated whether the patient carried a high 
risk of fracture requiring elective surgery. subsequently, 
we asked them to judge whether the cortical disruption 
caused by the metastasis was > 30 mm.14
Statistical analysis. Baseline data were compared between 
fracture and non-fracture group on the femur level using 
chi-squared test, Fisher’s exact test, or mann–Whitney 
u test, where applicable. We compared the failure load 
corrected for BW between the fractured and the non- 
fractured femurs using mann–Whitney u tests. For all 
tests, the level of significance was defined as p < 0.05.
To compare the clinical assessments with the predic-
tions by the Fe model, a critical Fe failure load was defined 
for the whole group, as well as for each institute sepa-
rately, classifying a patient to a high or a low fracture risk. 
more specifically, diagnostic accuracy values (sensitivity 
and specificity, and positive and negative predictive val-
ues (PPv and NPv)) were calculated for different thresh-
olds of a critical failure load using increments of 0.5 × 
BW. The threshold with the highest sum of specificity and 
sensitivity was chosen. For comparison with clinical 
assessments, we used the critical failure loads of the sepa-
rate institutes.
Results
Patients. in all, 39 patients with predominant lytic 
painful bone metastases were included in this study. 
one of the patients sustained a fracture of the femur 
one month after follow-up, and was included in the F 
group. This F group consisted of seven patients sustain-
ing nine fractures (Tables ii and iii). Two of these frac-
tures occurred in the contralateral femur that was not 
irradiated (the irradiated femurs of these patients were 
included in the NF group). additionally, two cases with 
an unknown cause of fracture were included. The NF 
group comprised a total of 34 patients with 38 treated 
non-fractured femurs (Table iii). There were no signifi-
cant differences in baseline characteristics between the 
F and NF group (Table iv).
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Fig. 2d
Femoral failure load for patients who did (F) or did not (NF) sustain a femoral fracture during follow-up, corrected for body weight (BW), a) in all institutes with-
out considering inter-scanner differences, and in b) institute 1, c) institute 2, and d) institute 3 separately. it should be noted that one femur (F87m) fractured one 
month after follow-up. The institutional thresholds were used to compare the predictive power of the finite element (Fe) model versus experienced clinicians. 
*Femur fractured during unknown activity; all other symbols (#, +, †, $, ‡, ¶, ¥, §) indicate paired femurs.
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Fe models. Figure 2 shows the BW-corrected failure 
loads for all femurs in this study together (Fig. 2a), 
as well as split to the three institutes (Figs 2b-d). The 
median failure load of all fractured femurs together was 
significantly lower compared with failure load of all 
non-fractured femurs (6.03 (interquartile range (iQr) 
4.80 to 7.33) vs 8.93 (iQr 7.10 to 9.85), p = 0.002). after 
splitting to individual institute to avoid inter-scanner 
differences, the median failure load of fractured femurs 
was significantly lower in institute 1 compared with fail-
ure load of the non-fractured femurs (4.89 (iQr 4.41 to 
6.55) vs 10.60 (iQr 8.46 to 11.90), p = 0.001). This was 
not the case for the femurs from institutes 2 and 3 (6.03 
vs 8.78 (iQr 7.04 to 9.12), p = 0.5 and 7.61 vs 8.61 (iQr 
6.12 to 10.44), p = 1).
We compared the actual fracture location with those 
predicted by the Fe models for eight out of nine femurs. 
in one case, no radiological information on clinical frac-
ture location was available. six out of eight Fe fracture 
locations resembled the actual fractures on post-fracture 
radiographs (Fig. 3). in the two other cases, the Fe mod-
els predicted femoral neck fractures, whereas these 
patients clinically presented with a pertrochanteric and 
diaphyseal fracture, respectively.
Clinical assessment. a critical failure load was defined for 
the whole group, as well as for each institute. The critical 
failure loads were 8.0 × BW for the whole group and 7.5 
× BW, 6.5 × BW, and 8.0 × BW for institutes 1, 2, and 
3, respectively (Fig. 2). When each institute was analyzed 
individually, the sensitivity remained the same, while the 
specificity increased from 0.63 to 0.79.
For comparison with clinical assessments, we used the 
critical failure loads of the separate institutes. more 
patients were correctly identified with a high fracture risk 
by the Fe model than by clinicians who relied on their 
clinical experience (Fig. 4), resulting in higher sensitivity 
of the Fe model (0.89) compared with the clinicians 
(ranging from 0.00 to 0.33; Table v). The Fe model iden-
tified 16 femurs with a high fracture risk, eight of which 
actually fractured during follow-up (PPv = 0.50). The PPv 
for clinicians ranged between 0.00 and 0.50. of the 38 
non-fractured femurs, the Fe model correctly identified 
30 femurs as having a low fracture risk (specificity = 
0.79). The specificity values for clinicians were slightly 
higher and ranged between 0.84 and 0.95, although the 
95% confidence intervals overlapped. The Fe model iden-
tified 31 femurs with a low fracture risk, of which 30 
indeed did not fracture (NPv = 0.97). NPv for clinicians 
were lower and ranged between 0.78 and 0.85.
When the experienced clinicians were asked to base 
their decision on 30 mm axial cortical disruption (Table v), 
their diagnostic accuracy values were comparable with 
the predictions based on clinical experience.
Discussion
Previously, we have shown that Fe models calculated the 
femoral load to failure comparably with those measured 
in mechanical experiments.11 in the current study, we 
Fig. 3
schematic overview of clinical fracture locations (upper panel), indicated by an experienced clinician who was blind to the predicted fracture locations, and 
the fracture locations at failure (mid-coronal plane) predicted by the finite element models (lower panel). Femurs indicated with + and # are paired femurs. F8 
fractured one month after follow-up (7m). There was no clinical information about fracture location available for F7.
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applied these Fe models in vivo by comparing the model 
predictions with clinical follow-up data in a prospective 
cohort of patients with cancer and painful femoral meta-
stases who were referred for palliative radiotherapy. We 
verified whether the model could have predicted the 
pathological fractures that some of the patients with 
painful bone metastases unexpectedly sustained during 
follow-up.
We showed a difference in median failure load 
between patients who sustained a pathological fracture 
and those who did not when we analyzed the whole 
group together as well as in institute 1. However, this 
difference was not present in the two other institutes, 
probably because of the low number of fractures. 
additionally, for two femurs in the latter institutes, the 
activity during which the fracture occurred was not 
recorded. We could therefore not confirm whether these 
fractures were pathological. if these fractures were trau-
matic, the high predicted failure loads as calculated by 
the Fe model would have been expected, with improved 
Fig. 4a Fig. 4b Fig. 4c
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correct and incorrect fracture predictions by the finite element (Fe) model and the experienced clinicians (c1, c2, c3) for a) institute 1, b) institute 2, and c) 
institute 3. clinicians judged the reconstructed radiographs of the patients based on their experience, without any further guidelines prescribed. For the Fe 
predictions thresholds of 7.5 × BW, 6.5 × BW, and 8.0 × BW for institute 1, 2, and 3, respectively, were used to indicate fracture (F) or non-fracture (NF). results 
are shown per group (F and NF). symbols (+, #, $, †, ‡, ¥, ¶, §) indicate paired femurs. F8 fractured one month after follow-up (7m).
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predictions as a result. Nevertheless, the results from 
institute 1 show that Fe models were able to compre-
hend many factors that contribute to the in vivo load 
capacity of metastatic femurs, such as the bone quality 
and the bone geometry, or compromise it, such as the 
location and the size of the lesion. goodheart et  al10 
recently found that Fe models can be used to distinguish 
between metastatic femurs that would and would not 
fracture. Positive findings were also shown in the field of 
osteoporosis (e.g. Keyak et  al,21 Kopperdahl et  al22), 
where Fe strength was found to highly correlate with 
fracture21 and Fe bone strength remained predictive for 
fracture after correction for total hip areal bone mineral 
density (aBmd) in men and women.22
in the present study, the Fe predictions demonstrated 
higher sensitivity compared with clinical assessments. 
This suggests a better identification of patients who will 
sustain a fracture by the Fe model, resulting in prevention 
of more pathological fractures. specificity of the Fe model 
was relatively high but slightly lower compared with the 
clinicians. However, NPv were very high (97%), indicat-
ing that if the Fe model predicts a low fracture risk, a frac-
ture almost never occurs. as a result, the Fe model could 
be clinically used to prevent unnecessary surgery. 
diagnostic values of the 30 mm cortical involvement 
from a previous study (sensitivity 86%, specificity 58%, 
PPv 23%, NPv 97%)5 were quite different from the clini-
cal assessment of the current study (Table v), showing 
that these values may be dependent on the clinicians 
and/or the studied patient group.
in six out of eight cases, the predicted fracture loca-
tion resembled the actual clinical fracture location. in 
cases F3 and F8, the Fe fracture locations did not resem-
ble the clinical fracture lines. F8 suffered from mixed 
metastases and clinically fractured through a lesion with 
higher cT density, which could explain why the Fe model 
did not predict the correct fracture location. since F3 
fractured spontaneously, the axial load applied in this 
study might be inappropriate to simulate the correct 
fracture line in this femur. modelling more and realistic 
loading conditions may further improve the predicted 
fracture location.
although the results in this study are promising, some 
limitations should be mentioned here. First of all, we real-
ize that the sample size in this study is limited, especially 
after splitting to institute. as a result, in institutes 2 and 3, 
the critical failure loads were based on only a few frac-
tures (n = 3 and n = 1), indicating the need for larger data 
sets in the near future. For that purpose, a solution to 
overcome inter-scanner differences should be developed, 
something we are currently working on.23
a second limitation in this study relates to the model-
ling of metastatic tissue. We excluded patients with pre-
dominant blastic femoral lesions from our analyses, as 
blastic lesions generally show very high cT intensities. in 
the current Fe model, these cT intensities would have 
been converted to material behaviour using relationships 
that are defined based on experiments with human tissue 
affected by metastases as well as healthy bone.7 Therefore, 
the empirical relationships have to be adapted for blastic 
metastatic tissue. so far, differences in microarchitecture 
have been described for metastases (e.g. sone et  al24), 
but the mechanical behaviour has not yet been estab-
lished unequivocally.25,26 moreover, adapted material 
models did not yet improve the predictive power of Fe 
models with metastatic lesions.27 Hence, further research 
is required to determine the mechanical behaviour of dif-
ferent types of metastatic tissue.
table V. summary statistics for the prediction accuracy of the finite element (Fe) model and the experienced clinicians when relying on their experience and 
when judging whether cortical involvement was larger than 30 mm.14 95% confidence intervals are given between brackets
F, n NF, n Sensitivity Specificity PPV NPV
Fe model whole group* F predicted 8 14 0.89 (0.52 to 1.00) 0.63 (0.46 to 0.78) 0.36 (0.26 to 0.48) 0.96 (0.79 to 0.99)
NF predicted 1 24  
Fe model split to institute† F predicted 8 8 0.89 (0.52 to 1.00) 0.79 (0.63 to 0.90) 0.50 (0.34 to 0.66) 0.97 (0.82 to 0.99)
NF predicted 1 30  
experience  
clinician 1 F predicted 2 2 0.22 (0.03 to 0.60) 0.95 (0.82 to 0.99) 0.50 (0.14 to 0.86) 0.84 (0.78 to 0.88)
NF predicted 7 36  
clinician 2 F predicted 0 6 0.00 (0.00 to 0.34) 0.84 (0.69 to 0.94) 0.00 0.78 (0.76 to 0.80)
NF predicted 9 32  
clinician 3 F predicted 3 3 0.33 (0.07 to 0.70) 0.92 (0.79 to 0.98) 0.50 (0.19 to 0.81) 0.85 (0.78 to 0.90)
NF predicted 6 35  
30 mm cortical involvement  
clinician 1 F predicted 2 1 0.22 (0.03 to 0.60) 0.97 (0.86 to 1.00) 0.67 (0.17 to 0.95) 0.84 (0.79 to 0.88)
NF predicted 7 37  
clinician 2 F predicted 1 6 0.11 (0.00 to 0.48) 0.84 (0.69 to 0.94) 0.14 (0.02 to 0.55) 0.80 (0.75 to 0.84)
NF predicted 8 32  
clinician 3 F predicted 0 1 0.00 (0.00 to 0.34) 0.97 (0.86 to 1.00) 0.00 0.80 (0.80 to 0.81)
NF predicted 9 37  
*Without considering inter-scanner differences
†Prediction of the Fe models based on different thresholds for each institute (institute 1: 7.5 × body weight (BW), institute 2: 6.5 × BW, institute 3: 8.0 × BW)
F, fracture group; NF, non-fracture group; PPv, positive predictive value; NPv, negative predictive value
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Third, the use of strain softening as a material property 
can cause mesh sensitivity and its use to capture localiza-
tion can be questioned. in the past, our group performed 
a sensitivity analysis by varying mesh density with or 
without applying a correction for element size. Based on 
a fit with experimental results, we decided to use the cur-
rent mesh density (average element volume of 1 mm3) 
without applying the correction. subsequently, we have 
been using the same protocol11 to minimize the differ-
ences between bones.
as a fourth limitation, it should be mentioned that the 
clinicians pointed out that the quality of the drrs was 
suboptimal compared with the conventional radio-
graphs they normally use, which may have affected their 
assessments.
in conclusion, we showed that patient-specific Fe 
models are a potential tool to improve clinical fracture 
risk predictions in patients with metastatic bone disease. 
The Fe models provided an accurate identification of 
patients with high fracture risk in one of the three insti-
tutes. Future work in a larger patient population should 
confirm the higher predictive power of the Fe models 
compared with current clinical guidelines. However, a 
robust solution to overcome inter-scanner differences 
should be developed before the Fe models can be exten-
sively used for clinical fracture risk assessments in a multi-
centre setting. in the future, the individual Fe outcome 
may help patients and their clinicians to weigh the chance 
of fracturing against choosing the most appropriate treat-
ment, which is either non-invasive radiotherapy to treat 
pain, or surgery to restore stability.
Supplementary material
a figure showing the substantially higher failure 
loads of femurs with blastic lesions in comparison 
with femurs with lytic or mixed lesions.
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